Are Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials

Background: Antipsychotic clinical trials use to present adverse events (AEs) for the drug under evaluation to treat schizophrenia. Interestingly, patients who receive the placebo during antipsychotic trials often report several AEs, but little is known about the essence of these negative effects in...

Descripción completa

Detalles Bibliográficos
Autores principales: Palermo, Sara, Giovannelli, Fabio, Bartoli, Massimo, Amanzio, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533921/
https://www.ncbi.nlm.nih.gov/pubmed/31156432
http://dx.doi.org/10.3389/fphar.2019.00502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533921/
https://www.ncbi.nlm.nih.gov/pubmed/31156432
http://dx.doi.org/10.3389/fphar.2019.00502

Ejemplares similares